Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: leftovers (7)

InP-Cisplatin(80)-Docetaxel(40)-Fluorouracil(2800)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (80)-DOCETAXEL(40)-FLUOROURACIL(2800) In-Patient Regimen Regimen • Head and Neck Cancer – InP-C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin80-Docetaxel40-Fluorouracil2800.pdf

Cisplatin (75)-Docetaxel(75)-Fluorouracil(4000)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (75)-DOCETAXEL(75)-FLUOROURACIL(4000) Regimen • Head and Neck Cancer – Cisplatin(75)-Docetaxel(
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-75-Docetaxel75-Fluorouracil4000.pdf

Cetuximab-Radiotherapy (7 day)

Description: Chemotherapy Protocol HEAD AND NECK CANCER CETUXIMAB RT (7 day) Regimen • Head and Neck Cancer – Cetuximab RT (7 day) Indication • Cetuximab in comb
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cetuximab-Radiotherapy7day.pdf

CH003 SOP regimen validation full

Description: Standard Operating Procedure Validation of Chemotherapy Protocols in ARIA (Wessex) (SOP:CH003) 1. Objective 1.1 The purpose of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH003-SOP-regimen-validation-full.pdf

Peptide receptor radionuclide therapy (PRRT) - patient information

Description: This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf

Olaparib Tablets

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCERS OLAPARIB (tablets) This regimen may require funding. Regimen • Ovarian Cancer – Olaparib (tablets) Ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Olaparib-Tablets.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

VAC31518COV2001_UK_Young Person_ Patient Information Sheet ICF_V2.0_15Feb2021_Clean Localised (3)

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO16 6YD Tel
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Young-Person-Patient-Information-Sheet-ICF-V2.0-15Feb2021-Clean-Localised-3.pdf

Dr Kristin Veighey, associate director and academic career development lead for medical clinical research fellows

Description: Southampton Academy of Research Auto Generated Title Dr Veighey aims to identify and promote research training opportunities for current and
Url: /ClinicalResearchinSouthampton/Our-people/Education-and-training-people/Dr-Kristin-Veighey-associate-director-and-academic-career-development-lead-for-medical-clinical-research-fellows.aspx

STHW841-V1-Biomerieux-Blood-culture-guidance

Description: BLOOD CULTURE A key investigation for diagnosis of bloodstream infections OUR SPECIAL THANKS GO TO Dr Susan M. Novak-Weekley Ph.D. D(ABMM), S(M)ASCP
Url: /Media/SUHTExtranet/DepartmentOfInfection/STHW841-V1-Biomerieux-Blood-culture-guidance.pdf

251 to 260 of 1000

Previous … 24 25 26 27 28 … Next